Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.69 +2.58 (+1.70%)
Streaming Delayed Price Updated: 1:20 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Johnson & Johnson MedTech Acquires Laminar, Inc.
From Johnson & Johnson MedTech
Via Business Wire
J&J, Gilead, BMS: A look at undervalued dividend payers
J&J, Gilead and Bristol Myers are among healthcare stocks with defensive qualities amid market volatility and a potential economic slowdown 
Via MarketBeat
2023's most anticipated IPOs weren't always the big winners
146 U.S. companies went public in 2023, down 16.09% from last year. Despite market ups and downs, the Renaissance index of IPOs is outperforming the S&P 500 
Via MarketBeat
Topics ETFs Initial Public Offering Stocks
Exposures Securities Market US Equities
Daily Wear Contact Lenses Market May See a Big Move: Major Giants Alcon, Hydron, Lagado Corporation, Metro Optics, Johnson & Johnson Vision Care
According to HTF Market Intelligence, the Global Daily Wear Contact Lenses Market Breakdown by Application (Corrective Lenses, Therapeutic Lenses, Cosmetic Lenses, Lifestyle-Oriented Lenses) by Type... 
Via SBWire
South Carolina Life Sciences Conference Expects Record Attendance, 30 National Speakers
GREENVILLE, S.C. - Nov. 14, 2023 - PRLog -- The largest life sciences conference in Palmetto State history will convene February 6-8 in Greenville, and national site selection consultants and media... 
Via PRLog
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Teva Pharma is the way to play the re-rise of generic drugs
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth 
Via MarketBeat
Heart Failure Drugs Market Critical Analysis with Expert Opinion : Johnson & Johnson, Pfizer, Roche
Global Heart Failure Drugs Market Breakdown by Application (Reduced Ejection Fraction, Preserved Ejection Fraction) by Type (ACE inhibitors, Beta Blockers, Diuretics, Sacubitril Valsartan, Others) by... 
Via SBWire
Skin Tightening Products Market to Witness Massive Growth by 2029 : L'Oréal, Johnson & Johnson, Amway
Stay up to date with Skin Tightening Products Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Memory Implants Market Set for More Growth : NextMind, Johnson & Johnson, Neuralink
Get Memory Implants Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis. 
Via SBWire
Johnson & Johnson to Host Enterprise Business Review
From Johnson & Johnson
Via Business Wire
Buffett's latest portfolio additions, trims and cuts in Q3
Buffett's Berkshire latest Q3 moves: Acquires Sirius XM, Atlanta Braves; trims HP, Chevron, Amazon; holds onto Apple, Bank of America. 
Via MarketBeat
Topics Regulatory Compliance
Exposures Legal Regulatory
Wall Street sees these 2023 losers as 2024 opportunities
Analysts are pointing at undervalued, oversold companies like these three S&P 500 laggards as potential investment opportunities heading into 2024. 
Via MarketBeat
Topics Stocks
Exposures US Equities
MarketBeat Week in Review – 10/30 - 11/3
Equities rallied as the theme of bad news is good news is back; investors now wait for the latest read on inflation and its impact on holiday spending 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
Via Investor Brand Network
Get Ready for Next Generation of Diabetes, Weight-Management Drugs
EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:JNJ),(NYSE:SNY),(NASDAQ:AMGN),(NYSE:NVS) EQNX::TICKER_END 
Via FinancialNewsMedia
Investor patience tested as pharmaceutical stocks take a tumble
The healthcare sector faces a selloff as pharmaceutical giants report lackluster earnings; even Amgen's strong results failed to prevent selling in the sector 
Via MarketBeat
J&J stock down as business unit mulls talc-related bankruptcy
Johnson & Johnson stock fell in the past week as talc-related lawsuits weigh on a subsidiary, which is mulling bankruptcy to mitigate payouts and settlements. 
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs. 
Via MarketBeat
Exposures COVID-19
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
From Johnson & Johnson
Via Business Wire
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
From Johnson & Johnson
Via Business Wire
Oversold and Overextended, Abbott Laboratories is a Great Buy
Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying. 
Via MarketBeat
Exposures COVID-19
Johnson & Johnson Reports Q3 2023 Results
From Johnson & Johnson
Via Business Wire
Steroids Market Is Set to Fly High in Years to Come : Pfizer, Johnson & Johnson, Bayer
Stay up to date with Steroids Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
3 Undervalued Healthcare Stocks to Watch as Sector Struggles
As the healthcare sector slumps, several major stocks, including Zimmer Biomet, Moderna, and Illumina, appear undervalued in contrast to their intrinsic worth. 
Via MarketBeat
3 Blue Chip Safe Havens to Shield Your Portfolio
As the market experiences heightened volatility and uncertainty, it's worth exploring defensive stocks like JNJ, PG, and VZ for stability amid the uncertainty. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
3 Reasons SharkNinja Is Swimming Toward New Highs
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders. 
Via MarketBeat
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Exposures Economy Product Safety
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback